Royal Bank of Canada Issues Pessimistic Forecast for Tandem Diabetes Care (NASDAQ:TNDM) Stock Price
Tandem Diabetes Care (NASDAQ:TNDM – Get Free Report) had its price target decreased by Royal Bank of Canada from $65.00 to $55.00 in a research note issued on Thursday,Benzinga reports. The brokerage presently has an “outperform” rating on the medical device company’s stock. Royal Bank of Canada’s price objective would suggest a potential upside of […]
Tandem Diabetes Care (NASDAQ:TNDM – Get Free Report) had its price target decreased by Royal Bank of Canada from $65.00 to $55.00 in a research note issued on Thursday,Benzinga reports. The brokerage presently has an “outperform” rating on the medical device company’s stock. Royal Bank of Canada’s price objective would suggest a potential upside of […]
